Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study.
Galiero R, Simeon V, Loffredo G, Caturano A, Rinaldi L, Vetrano E, Medicamento G, Alfano M, Beccia D, Brin C, Colantuoni S, Di Salvo J, Epifani R, Nevola R, Marfella R, Sardu C, Coppola C, Scarano F, Maggi P, Calabrese C, De Lucia Sposito P, Rescigno C, Sbreglia C, Fraganza F, Parrella R, Romano A, Calabria G, Polverino B, Pagano A, Numis FG, Bologna C, Nunziata M, Esposito V, Coppola N, Maturo N, Nasti R, Di Micco P, Perrella A, Lettieri M, Adinolfi LE, Chiodini P, Sasso FC, On Behalf Of Covoca Study Group. Galiero R, et al. Among authors: perrella a. J Clin Med. 2022 Oct 17;11(20):6121. doi: 10.3390/jcm11206121. J Clin Med. 2022. PMID: 36294442 Free PMC article.
Interleukin 10 and transforming growth factor beta 1 in hepatic fibrosis.
Perrella O, Perrella M, Cusumano V, Ibello U, Sbreglia C, De Sena R, Perrella A. Perrella O, et al. Among authors: perrella m, perrella a. Int J Immunopathol Pharmacol. 2002 Sep-Dec;15(3):243-244. doi: 10.1177/039463200201500312. Int J Immunopathol Pharmacol. 2002. PMID: 12575926 Free article. No abstract available.
Antiviral therapy in acute viral hepatitis B: why and when.
Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O. Morelli G, et al. Among authors: perrella a, perrella o. Infect Agent Cancer. 2009 Jan 16;4:2. doi: 10.1186/1750-9378-4-2. Infect Agent Cancer. 2009. PMID: 19149879 Free PMC article.
Antiviral therapy in acute viral hepatitis B: why and when.
Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Monaco A, Perrella O. Morelli G, et al. Among authors: perrella a, perrella o. Infect Agent Cancer. 2009 Apr 1;4:5. doi: 10.1186/1750-9378-4-5. Infect Agent Cancer. 2009. PMID: 19338663 Free PMC article.
Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral hepatitis B: why and when. ...
Correction to Morelli G, Perrella A, Sbreglia C, Bellopede P, Riccio V, Perrella O: Antiviral therapy in acute viral he …
Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
Perrella A, Sbreglia C, Atripaldi L, Esposito C, D'Antonio A, Perrella O. Perrella A, et al. Among authors: perrella o. Scand J Gastroenterol. 2010;45(2):250-5. doi: 10.3109/00365520903428614. Scand J Gastroenterol. 2010. PMID: 19968615
194 results